Patient monitoring services (sample analyses) are supported using the cell based iLite™ technology platform.
Concentration/activity analysis and immunogenicity testing are available for:
- Interferons (IFNα/INFβ), e.g. Rebif®, Avonex®, Betaferon® (Betaseron®), Actimmune®, Pegasys®, PegIntron®, Pegetron®, Roferon A®, Intron A® and Multiferon®.
- Anti-tumor necrosis factor alpha biologicals (TNFα modulators), e.g. Adalimumab (Humira®, Exemptia®), Certolizumab pegol (Cimzia®), Etanercept (Enbrel®), Golimumab (Simponi®) and Infliximab (Remicade®, Remsima®, Inflectra®).
Please send sample analysis requests here.